A detailed history of Engine Capital Management, LP transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Engine Capital Management, LP holds 1,289,949 shares of TSVT stock, worth $3.91 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares
1,289,949
Previous 1,494,304 13.68%
Holding current value
$3.91 Million
Previous $5.75 Million 5.82%
% of portfolio
1.18%
Previous 1.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.85 - $5.05 $786,766 - $1.03 Million
-204,355 Reduced 13.68%
1,289,949 $6.09 Million
Q4 2023

Feb 14, 2024

BUY
$1.57 - $4.58 $1.81 Million - $5.28 Million
1,152,434 Added 337.1%
1,494,304 $6.38 Million
Q3 2023

Nov 14, 2023

BUY
$3.14 - $11.2 $1.07 Million - $3.83 Million
341,870 New
341,870 $1.34 Million

Others Institutions Holding TSVT

About 2seventy bio, Inc.


  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $115M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Engine Capital Management, LP Portfolio

Follow Engine Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engine Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Engine Capital Management, LP with notifications on news.